Search Results for: als

Fractals, fibonacci, & food: romanesco wows in garden

Romanesco-Knoepfler

As some of you readers know, in addition to being a scientist, I’m also an avid gardener and photographer. Every now and then I do posts on gardening or photography. I feel like I bring a scientist’s eye to the garden and that was true a few days ago when I captured the above picture of …

Fractals, fibonacci, & food: romanesco wows in garden Read More »

Good stem cell news on trials, FDA, cool new papers & more

Pericyte-paper

In the whirlwind that is the stem cell and regenerative medicine world, there are many concerning things that need attention, but also good stuff happens too and this post focuses on the positive. The Asterias spinal cord injury clinical trial, a phase 1/2a trial called SCiStar, continues to make encouraging news with a clean safety profile …

Good stem cell news on trials, FDA, cool new papers & more Read More »

Text mining hottest 50 papers reveals hottest 2016 stem cell trends

Top-stem-cell-pub-word-cloud

What are the hottest stem cell trends in the field today? Depends who you ask, right? One impartial way to look at stem cell trends is through the lens of publication citations and the focuses of top stem cell papers. In that perhaps somewhat skewed, but interesting approach, the words used in the titles of the …

Text mining hottest 50 papers reveals hottest 2016 stem cell trends Read More »

Asterias interview: stem cell spinal cord injury trials advance

Asterias

Recently I had the opportunity to talk with the leadership of Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth. How …

Asterias interview: stem cell spinal cord injury trials advance Read More »

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate

Harada-Family-e1479769086296

It takes a great deal of courage to participate in a clinical trial, patients who make that choice are heroes in my book and one such hero with stem cells was Ted Harada who had ALS. Sadly, Ted passed away from a brain tumor called glioblastoma last month. When enrolling in a trial, you just never …

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate Read More »

Where to submit my paper? A guide to stem cell journals

Cell-Stem-Cell

So you’ve got a great draft paper on stem cells or regenerative medicine, but you’re wondering, “Which of the stem cell journals do I submit it too?” I get asked this question fairly often so I decided to do a post on it. Sometimes I ask myself this question about a paper we have nearly …

Where to submit my paper? A guide to stem cell journals Read More »

Stem cells for goals? Star Ronaldo to get treatment

Ronaldo-stem-cells

Superstar soccer/football player Cristiano Ronaldo will reportedly undergo a stem cell treatment procedure to try to mend a hamstring injury. He is one in a long line of sports stars who are taking this gamble. This is reported by the highly rigorous source, The Daily Mail as well as the Independent. The latter quoted his mother …

Stem cells for goals? Star Ronaldo to get treatment Read More »

Poll: How do you feel about ‘pay-to-play’ clinical trials?

6a00e55417fcfd8834014e869e537f970d-600wi

There’s a growing trend whereby patients have to pay to be in a clinical trial. This is now widely referred to as “pay-to-play”. Proponents of this idea point toward potential benefits in the form of patients gaining access to innovative therapies. They also argue that this approach provides a much-needed funding mechanism for the trials …

Poll: How do you feel about ‘pay-to-play’ clinical trials? Read More »

CRISPR embryo OK signals ongoing liberal UK trend on human modification

Kathy-Niakan

With the approval today of the use of CRISPR in human embryos, the UK continues its recent trend toward a more permissive regulatory policy on human genetic modification. There are both risks and scientific benefits that come along with this trend. Last year the UK approved an experimental technology with the goal of preventing the …

CRISPR embryo OK signals ongoing liberal UK trend on human modification Read More »